NCT06451133

Brief Summary

The purpose of this study is to assess the effect of various hemodynamic management strategies on functional neurologic outcomes and non-neurologic adverse events in the first 5 days following acute spinal cord injury (SCI). The hemodynamic management strategies assessed include targeting a mean arterial blood pressure (MAP) goal of 85-90 mmHg, targeting a spinal cord perfusion pressure (SCPP) goal of ≥65 mmHg, or targeting normal hemodynamics, which is a MAP goal of ≥65 mmHg.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
228

participants targeted

Target at P75+ for not_applicable

Timeline
2mo left

Started Jul 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Jul 2024Jul 2026

First Submitted

Initial submission to the registry

June 4, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 11, 2024

Completed
22 days until next milestone

Study Start

First participant enrolled

July 3, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2025

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Expected
Last Updated

December 11, 2024

Status Verified

December 1, 2024

Enrollment Period

1.2 years

First QC Date

June 4, 2024

Last Update Submit

December 5, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • The severity of a spinal cord injury (SCI) as assessed by the American Spinal Injury Association (ASIA) International Standards for Neurological Classification of Spinal Cord Injury (ISNCSC) motor score

    Upper and lower extremities will be assessed, and motor strength at each spinal cord level will be scored from 0 to 5 (0 indicates total paralysis and 5 indicates active movement against full resistance), with a maximum score of 25 for each extremity, totaling 100 for all four extremities. Total score ranges from 0 to 100, with a higher score indicating a better outcome.

    6 weeks following injury

  • Performance in activities of daily living and mobility as assessed by the Spinal Cord Independence Measure (SCIM) III score

    There are 3 subscales on the SCIM III: self-care (4 items, score ranging from 0-20), respiration and sphincter management (4 items, score ranging from 0-40), and mobility (9 items, score ranging from 0-40). Total score ranges from 0 to 100, with a higher score indicating a better outcome.

    6 weeks following injury

Secondary Outcomes (10)

  • Change in motor function as assessed by the American Spinal Injury Association (ASIA) International Standards for Neurological Classification of Spinal Cord Injury (ISNCSC) motor score

    6 months following injury, 12 months following injury

  • Change in sensory function as assessed by the American Spinal Injury Association (ASIA) International Standards for Neurological Classification of Spinal Cord Injury (ISNCSC) sensory score

    6 months following injury, 12 months following injury

  • Change in performance in activities of daily living and mobility as assessed by the Spinal Cord Independence Measure (SCIM) III score

    6 months following injury, 12 months following injury

  • Number of ICU-free days

    30 days from baseline

  • Duration of time (hours) receiving goal caloric requirements by enteric nutrition

    first 5 days of hospitalization

  • +5 more secondary outcomes

Study Arms (3)

Mean arterial blood pressure (MAP) goal of ≥65 mmHg

EXPERIMENTAL
Other: Mean arterial blood pressure (MAP) goal of ≥65 mmHg

Mean arterial blood pressure (MAP) goal of 85-90 mmHg

EXPERIMENTAL
Other: Mean arterial blood pressure (MAP) goal of 85-90 mmHg

Spinal cord perfusion pressure (SCPP) goal of ≥65 mmHg

EXPERIMENTAL
Other: Spinal cord perfusion pressure (SCPP) goal of ≥65 mmHg

Interventions

The treatment team will maintain MAP ≥65 mmHg for the first five days following injury.

Mean arterial blood pressure (MAP) goal of ≥65 mmHg

The treatment team will maintain MAP 85-90 mmHg for the first five days following injury.

Mean arterial blood pressure (MAP) goal of 85-90 mmHg

The treatment team will maintain SCPP ≥65 mmHg for the first five days following injury.

Spinal cord perfusion pressure (SCPP) goal of ≥65 mmHg

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Traumatic spinal cord injury

You may not qualify if:

  • Patients with an injury from a trauma that penetrates the spinal cord (i.e., gunshot or knife wound resulting in cord transection)
  • Preexisting neurologic or spinal cord injury
  • Severe traumatic brain injury as measured by a best resuscitated Glasgow Coma Scale (GCS) score of \<8 at 24 hours following injury
  • Presence of traumatic injuries that preclude spine surgery within 24 hours of presentation
  • Concomitant injury/illness requiring targeted blood pressure management (e.g., injury to the aorta, aortic dissection, hemorrhagic stroke)
  • Preexisting history of neuromotor disorders (i.e., cerebral palsy, Parkinson disease, etc.)
  • Not expected to survive \>24h
  • Cord transection identified by radiologist and agreed upon by the spine surgery team
  • Injury below spinal cord level L1
  • Prisoners
  • Pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

RECRUITING

MeSH Terms

Conditions

Spinal Cord Injuries

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Study Officials

  • David Meyer, MD, MS, FACS

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 4, 2024

First Posted

June 11, 2024

Study Start

July 3, 2024

Primary Completion

September 15, 2025

Study Completion (Estimated)

July 31, 2026

Last Updated

December 11, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations